NCT03718364 Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry
| NCT ID | NCT03718364 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Catheter-based Ablation of Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2010-07-01 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2010-07-01 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).
Eligibility Criteria
Inclusion Criteria: * patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) Exclusion Criteria: * Patients not able or willing to participate in this study
Contact & Investigator
Michael Kuehne, MD
PRINCIPAL INVESTIGATOR
Cardiology/Electrophysiology, University Hospital Basel
Frequently Asked Questions
Who can join the NCT03718364 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Catheter-based Ablation of Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03718364 currently recruiting?
Yes, NCT03718364 is actively recruiting participants. Contact the research team at michael.kuehne@usb.ch for enrollment information.
Where is the NCT03718364 trial being conducted?
This trial is being conducted at Basel, Switzerland, Bern, Switzerland.
Who is sponsoring the NCT03718364 clinical trial?
NCT03718364 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Michael Kuehne, MD at Cardiology/Electrophysiology, University Hospital Basel. The trial plans to enroll 3,000 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.